Imperial College London Featured PhD Programmes
Gdansk University of Technology Featured PhD Programmes
University of Reading Featured PhD Programmes

pancreatic cancer PhD Projects, Programmes & Scholarships

We have 16 pancreatic cancer PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 16 pancreatic cancer PhD Projects, Programmes & Scholarships

PhD saved successfully

Second generation nano-carriers for pancreatic cancer therapy

Hybrid iron oxide-gold nanoparticles have been shown to have great potential as theranostic agents for cancer therapy. The iron oxide core can be used for diagnostic imaging using MRI whilst the gold surface possesses unique optimal properties. Read more

The Influence of hybrid nanoparticle architecture on theranostic abilities in pancreatic cancer

We are looking to recruit a PhD student with a relevant chemical, pharmaceutical, biomedical science or bioengineering background to design and develop novel nanomedicine platforms for chemotherapy. Read more

Cutting off the fuel supply to calcium pumps in pancreatic cancer: a novel therapeutic strategy

Background and Rationale. Pancreatic ductal adenocarcinoma (PDAC) has the poorest survival and limited treatment options. Therefore, the search for novel therapeutic targets and drugs designed to selectively kill PDAC cells must remain a central research strategy. Read more

MVLS/EPSRC - Deconvolution of intra-tumouralheterogeneity using whole section images in pancreatic cance

  Research Group: Institute of Cancer Sciences
Molecular subtyping is a methodology to subclassify cancer that looks otherwise very similar under the microscope and is essential to better define molecular taxonomy of prognosis and treatment response. Read more

Biological significance, predictive value and targeting of cell surface antigens in colorectal cancer.

Despite major advances in its early detection, preventive measures and therapeutic options, colorectal cancer is the fourth most commonly diagnosed cancer and the third leading cause of cancer deaths worldwide. Read more

Understanding the pro- and anti-tumour functions of IFNγ-producing γδ T cells

TO APPLY CLICK 'INSTITUTION WEBSITE' . γδ T cells are a rare population of T cell receptor-expressing cells that function like innate immune cells.γδ T cells consist of several different subtypes that can promote or prevent cancer progression, depending on the cytokines and cytotoxic molecules they express. Read more

How the interactome defines the biological activity of members of the KDM4A subfamily of histone demethylases.

The expression of members of the KDM4A-subfamily of histone demethylases is impaired in various cancers. Different signalling pathways regulate the KDM4A-subfamily interactome, thereby affecting the biological activity of these enzymes. Read more

Cancer cells ‘feed’ on extracellular matrix components under starvation conditions: how can they do it?

Background. The tumour microenvironment (TME) has a key role in promoting tumour formation and progression. In breast and pancreatic cancers, this accompanied by the accumulation of extracellular matrix (ECM) in the TME. Read more

Novel therapeutics in breast, pancreatic and colorectal cancers

The host laboratories based in the European Cancer Stem Cell Research Institute, School of Biosciences and the School of Pharmaceutical Sciences, University of Cardiff have developed two novel classes of therapeutic agent for oncology that target two distinct cancer cell pathways. Read more

Filtering Results